Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice
- PMID: 26900923
- PMCID: PMC5984042
- DOI: 10.1038/nn.4256
Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice
Abstract
To gain insight into how mutant huntingtin (mHtt) CAG repeat length modifies Huntington's disease (HD) pathogenesis, we profiled mRNA in over 600 brain and peripheral tissue samples from HD knock-in mice with increasing CAG repeat lengths. We found repeat length-dependent transcriptional signatures to be prominent in the striatum, less so in cortex, and minimal in the liver. Coexpression network analyses revealed 13 striatal and 5 cortical modules that correlated highly with CAG length and age, and that were preserved in HD models and sometimes in patients. Top striatal modules implicated mHtt CAG length and age in graded impairment in the expression of identity genes for striatal medium spiny neurons and in dysregulation of cyclic AMP signaling, cell death and protocadherin genes. We used proteomics to confirm 790 genes and 5 striatal modules with CAG length-dependent dysregulation at the protein level, and validated 22 striatal module genes as modifiers of mHtt toxicities in vivo.
Conflict of interest statement
The authors declare that they have no competing interests that might be perceived to influence the results and/or discussion reported in this article.
Figures
Similar articles
-
Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.Hum Mol Genet. 2006 Jun 15;15(12):2015-24. doi: 10.1093/hmg/ddl125. Epub 2006 May 10. Hum Mol Genet. 2006. PMID: 16687439
-
Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.J Neurochem. 2001 Aug;78(4):694-703. doi: 10.1046/j.1471-4159.2001.00482.x. J Neurochem. 2001. PMID: 11520890
-
Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.Free Radic Biol Med. 2012 Nov 15;53(10):1857-67. doi: 10.1016/j.freeradbiomed.2012.09.004. Epub 2012 Sep 14. Free Radic Biol Med. 2012. PMID: 22982598
-
The selective vulnerability of nerve cells in Huntington's disease.Neuropathol Appl Neurobiol. 2001 Feb;27(1):1-21. doi: 10.1046/j.0305-1846.2001.00299.x. Neuropathol Appl Neurobiol. 2001. PMID: 11298997 Review.
-
Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.J Neurochem. 2010 Jul;114(1):1-12. doi: 10.1111/j.1471-4159.2010.06741.x. Epub 2010 Apr 9. J Neurochem. 2010. PMID: 20403078 Review.
Cited by
-
Negative feedback control of neuronal activity by microglia.Nature. 2020 Oct;586(7829):417-423. doi: 10.1038/s41586-020-2777-8. Epub 2020 Sep 30. Nature. 2020. PMID: 32999463 Free PMC article.
-
HSF1 and Its Role in Huntington's Disease Pathology.Adv Exp Med Biol. 2023;1410:35-95. doi: 10.1007/5584_2022_742. Adv Exp Med Biol. 2023. PMID: 36396925 Review.
-
A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases.Front Mol Neurosci. 2022 Sep 14;15:974167. doi: 10.3389/fnmol.2022.974167. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36187346 Free PMC article. Review.
-
Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models.Cell Rep. 2020 Jul 14;32(2):107908. doi: 10.1016/j.celrep.2020.107908. Cell Rep. 2020. PMID: 32668255 Free PMC article.
-
Meta-gene markers predict meningioma recurrence with high accuracy.Sci Rep. 2020 Oct 22;10(1):18028. doi: 10.1038/s41598-020-74482-2. Sci Rep. 2020. PMID: 33093491 Free PMC article.
References
-
- Ross CA, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature reviews. Neurology. 2014;10:204–216. - PubMed
-
- Vonsattel JP, DiFiglia M. Huntington disease. Journal of neuropathology and experimental neurology. 1998;57:369–384. - PubMed
-
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell. 1993;72:971–983. - PubMed
-
- Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annual review of neuroscience. 2007;30:575–621. - PubMed
-
- Gusella JF, MacDonald ME. Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nature reviews. Neuroscience. 2000;1:109–115. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
